5-[[1-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]-(4-methyl-1-oxo-1-sulfooxypentan-2-yl)amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-[[1-[2-[[4-carboxy-2-[[4-carboxy-2-[[2-[[3-carboxy-2-[[2-[(2,4-diamino-4-oxobutanoyl)amino]acetyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]butanoyl]amino]butanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid (BioDeep_00000913133)

   


代谢物信息卡片


5-[[1-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]-(4-methyl-1-oxo-1-sulfooxypentan-2-yl)amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-[[1-[2-[[4-carboxy-2-[[4-carboxy-2-[[2-[[3-carboxy-2-[[2-[(2,4-diamino-4-oxobutanoyl)amino]acetyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]butanoyl]amino]butanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid

化学式: C65H91N13O28S (1533.5816926)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N(C(CC(C)C)C(=O)OS(=O)(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)N
InChI: InChI=1S/C65H91N13O28S/c1-5-33(4)54(76-58(95)41(19-23-51(86)87)71-56(93)39(17-21-49(82)83)72-59(96)43(28-34-10-7-6-8-11-34)75-60(97)44(30-53(90)91)70-48(81)31-69-55(92)37(66)29-47(68)80)64(101)77-25-9-12-45(77)61(98)73-40(18-22-50(84)85)57(94)74-42(20-24-52(88)89)63(100)78(46(26-32(2)3)65(102)106-107(103,104)105)62(99)38(67)27-35-13-15-36(79)16-14-35/h6-8,10-11,13-16,32-33,37-46,54,79H,5,9,12,17-31,66-67H2,1-4H3,(H2,68,80)(H,69,92)(H,70,81)(H,71,93)(H,72,96)(H,73,98)(H,74,94)(H,75,97)(H,76,95)(H,82,83)(H,84,85)(H,86,87)(H,88,89)(H,90,91)(H,103,104,105)

描述信息

D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents > D006629 - Hirudins

同义名列表

1 个代谢物同义名

5-[[1-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]-(4-methyl-1-oxo-1-sulfooxypentan-2-yl)amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-[[1-[2-[[4-carboxy-2-[[4-carboxy-2-[[2-[[3-carboxy-2-[[2-[(2,4-diamino-4-oxobutanoyl)amino]acetyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]butanoyl]amino]butanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid



数据库引用编号

1 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Chin-Chung Wu, Wei-Ya Wang, Chien-Kei Wei, Che-Ming Teng. Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets. Thrombosis and haemostasis. 2011 Jan; 105(1):88-95. doi: 10.1160/th10-05-0305. [PMID: 21057701]
  • N J Mutch, T Myles, L L K Leung, J H Morrissey. Polyphosphate binds with high affinity to exosite II of thrombin. Journal of thrombosis and haemostasis : JTH. 2010 Mar; 8(3):548-55. doi: 10.1111/j.1538-7836.2009.03723.x. [PMID: 20002544]
  • N B de Bosch, M W Mosesson, A Ruiz-Sáez, M Echenagucia, A Rodriguez-Lemoin. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thrombosis and haemostasis. 2002 Aug; 88(2):253-8. doi: 10.1055/s-0037-1613195. [PMID: 12195697]
  • S J Bauman, F C Church. Enhancement of heparin cofactor II anticoagulant activity. The Journal of biological chemistry. 1999 Dec; 274(49):34556-65. doi: 10.1074/jbc.274.49.34556. [PMID: 10574918]
  • F A Ofosu, J W Fenton, J Maraganore, M A Blajchman, X Yang, L Smith, N Anvari, M R Buchanan, J Hirsh. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. The Biochemical journal. 1992 May; 283 ( Pt 3)(?):893-7. doi: 10.1042/bj2830893. [PMID: 1590777]
  • M C Naski, L Lorand, J A Shafer. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. Biochemistry. 1991 Jan; 30(4):934-41. doi: 10.1021/bi00218a008. [PMID: 1989686]
  • F A Ofosu. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII. Haemostasis. 1991; 21(4):240-7. doi: 10.1159/000216232. [PMID: 1794749]
  • M A DeMichele, D G Moon, J W Fenton, F L Minnear. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. Journal of applied physiology (Bethesda, Md. : 1985). 1990 Nov; 69(5):1599-606. doi: 10.1152/jappl.1990.69.5.1599. [PMID: 2272952]
  • J I Weitz, M Hudoba, D Massel, J Maraganore, J Hirsh. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. The Journal of clinical investigation. 1990 Aug; 86(2):385-91. doi: 10.1172/jci114723. [PMID: 2384594]
  • J A Jakubowski, J M Maraganore. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood. 1990 Jan; 75(2):399-406. doi: NULL. [PMID: 2294999]